Neil is the Fineberg of Fineberg Ramamoorthy LLP. With a background in chemistry/pre-medical studies and 20+ years of experience in the pharmaceutical space, Neil applies both legal and technical expertise to his litigation and regulatory practice. Opinion work, Notice of Allegation drafting, pleading preparation, written and oral advocacy and generally advising clients on their legal and regulatory prospects all fall within the scope of Neil’s practice.

Neil has appeared before the Federal Court, Federal Court of Appeal, the Supreme Court of Canada (technically anyway) and the Patented Medicines Prices Review Board.

Kavita Ramamoorthy
  • Called to the Ontario Bar, 2003
  • Registered Canadian Patent Agent, 2004 (Class 4, 2024)
  • Registered Canadian Trade-Mark Agent, 2005 (Class 4, 2024)
  • LLB, University of Western Ontario
  • B.Sc. (Hons), Chemistry and Human Biology, University of Toronto
  • Member of the Canadian Bar Association and the Ontario Bar Association
  • Member of the IP Users Committee of the Federal Court
  • Fellow of the Intellectual Property Institute of Canada (IPIC)
  • Member of the IPIC Litigation Committee
  • Past Member of the IPIC Anti-Counterfeiting Committee and the IPIC International Trademark Issues Committee
  • Member of the editorial board of the Canadian Intellectual Property Review (CIPR)
  • Best Lawyers in Canada – Intellectual Property Law
  • Business Today
  • Chambers and Partners – Intellectual Property: Litigation
  • IAM Patent 1000
  • Lexpert
  • Who's Who Legal: Life Sciences
  • Eli Lilly Canada Inc. v. Novopharm Ltd. et al, 2007 FC 596
  • Eli Lilly Canada Inc. et al. v. Teva Canada Limited, 2009 FC 1018; 2011 FC 1288
  • Eli Lilly Canada Inc. et al. v. Novopharm Limited, 2010 FCA 197
  • Eli Lilly Canada Inc. et al. v. Novopharm Ltd., 2012 FCA 232
  • Ratiopharm Inc. (Now Teva Canada Limited) v. Attorney General of Canada, 2014 FC 502
  • Sandoz Canada Inc. v. AGC, 2014 FC 501

* Practicing through a professional corporation.